Robert Brainin
CEO & DirectorMr. Robert Brainin, also known as Rob, had been Executive Vice President at Veracyte, Inc. since July 2021 and served as it's Chief Business Officer since July 2021 until 2025. He serves as Director at Champions Oncology Inc. since February 8, 2021 and serves as its Chief Executive Officer since August 25, 2025. He was the Chief Executive Officer of Genuity Science from March 2018 to January 2021, also serving as a director from June 2020 until January 2021. He joined Genuity as the Chief Operating Officer in August 2017. Mr. Brainin served as Executive Vice President and Chief Operating Officer at WuXi NextCODE Genomics since August 2017 until March 2018. Before joining Genuity, he was Vice President and General Manager of Life Sciences and Applied Genomics at Illumina (from 2016 to August 2017), having previously served as VP and Head of the Arrays Business (from 2015 to 2016). Mr. Brainin has also held senior roles at Thermo Fisher (from 2013 to 2015), Life Technologies (from 2008 to 2013) and Invitrogen (from 2004 to 2008). Mr. Brainin has experience leading the product development, market development and commercialization of life sciences and genomics technologies. From 1997 to 2000, he was a management consultant at McKinsey & Company after attending Harvard Law School. In his career, he has served as an adjunct professor at the University of San Diego School of Law. Mr. Brainin holds Bachelor of Arts degree in economics from Emory University and J.D., cum laude, from Harvard Law School.
Positions
- Company NameChampions Oncology, Inc.Stock CodeCSBRPositionCEO & DirectorColleagues
- RMRonnie MorrisExecutive Chair
- DBDavid Barry MillerChief Financial Officer
- MMMaria ManciniChief Operating Officer
- MZMarianna ZipetoExecutive Vice President of Growth, Strategy & Enablement
- SRScott Russell TobinIndependent Director
- MHManuel Hidalgo MedinaScientific Advisor
- DSDavid SidranskyIndependent Director
